ALFA News
Straight from the exchange filing
Every announcement Fredun Pharmaceuticals has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Fredun Pharmaceuticals announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Fredun Pharmaceuticals allotted 44,000 equity shares to non-promoters after converting 14,667 warrants, adjusted for a bonus issue at a 3:1 ratio in October 2026.
Fredun Pharmaceuticals launches PAWTALKS, a digital platform for animal healthcare, as its net profit grows 94.1% YoY to ₹13.13 Cr in the latest quarter.
